Can we improve the cytologic examination of malignant pleural effusions using molecular analysis?

Annals of Thoracic Surgery

Volumn 80, Issue 4, 2005, Pages 1241-1247

  Brock, Malcolm V ^a   Hooker, Craig M ^a   Yung, Rex ^a   Guo, Mingzhou ^a   Han, Yu ^a   Ames, Stephen E ^a   Chang, David ^a   Yang, Stephen C ^a   Mason, David ^a   Sussman, Marc ^a   Baylin, Stephen B ^a   Herman, James G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; DNA EXTRACTION; DNA METHYLATION; FEMALE; HOSPITAL PATIENT; HUMAN; MALE; PLEURA EFFUSION; PLEURA FLUID; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL;

BREAST NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; COHORT STUDIES; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MOLECULAR DIAGNOSTIC TECHNIQUES; PLEURAL EFFUSION, MALIGNANT; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 25144488149     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2005.05.088     Document Type: Article

References (41)

1. V.B. Antony, R. Loddenkemper, P. Astoul Management of malignant pleural effusions Eur Respir J 18 2001 402 419
2. R.C. Yung, M.V. Brock Diagnosis and management of pleural metastases in breast cancer K.I. Bland E.M. Copeland The breast comprehensive management of benign and malignant disorders Vol 2 2004 Saunders St Louis 1395 1406
3. R. Loddenkemper, C. Boutin Thoracoscopy present diagnostic and therapeutic indications Eur Respir J 6 1993 1544 1555
4. K.N. Fenton, J.D. Richardson Diagnosis and management of malignant pleural effusions Am J Surg 170 1995 69 74
5. M.G. Joseph, D. Banerjee, P. Harris Multiparameter flow cytometric DNA analysis of effusions a prospective study of 36 cases compared with routine cytology and immunohistochemistry Mod Pathol 8 1995 686 693
6. S.A. Sahn, J.T. Good Jr Pleural fluid pH in malignant effusions. Diagnostic, prognostic, and therapeutic implications Ann Intern Med 108 1988 345 349
7. B. Chernow, S.A. Sahn Carcinomatous involvement of the pleura an analysis of 96 patients Am J Med 63 1977 695 702
8. F.J. van de Molengraft, G.P. Vooijs Survival of patients with malignancy-associated effusions Acta Cytol 33 1989 911 916
9. M.V. Brock Pleural effusions K.D. Lillemoe R.D. Schulick Pocket General Surgery 2004 Pocketmedicine.com. NY
10. C. Boutin, J.R. Viallat, P. Cargnino, P. Farisse Thoracoscopy in malignant pleural effusions Am Rev Respir Dis 124 1981 588 592
11. R. Menzies, M. Charbonneau Thoracoscopy for the diagnosis of pleural disease Ann Intern Med 114 1991 271 276
12. M.M. DeCamp Jr., M.T. Jaklitsch, S.J. Mentzer The safety and versatility of video-thoracoscopy a prospective analysis of 895 consecutive cases J Am Coll Surg 181 1995 113 120
13. M. Miedouge, P. Rouzaud, G. Salama Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions Br J Cancer 81 1999 1059 1065
14. P. Ferroni, C. Szpak, J.W. Greiner CA 72-4 radioimmunoassay in the diagnosis of malignant effusions. Comparison of various tumor markers Int J Cancer 46 1990 445 451
15. M.V. Brock, M. Gou, Y. Akiyama Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma Clin Cancer Res 9 2003 2912 2919
16. J.G. Herman, S.B. Baylin Promoter-region hypermethylation and gene silencing in human cancer Curr Top Microbiol Immunol 249 2000 35 54
17. S.B. Baylin, S.A. Belinsky, J.G. Herman Aberrant methylation of gene promoters in cancer-concepts, misconcepts, and promise J Natl Cancer Inst 92 2000 1460 1461
18. M. Guo, M.V. Brock Promoter hypermethylation of resected bronchial margins a field defect of changes? Clin Cancer Res 10 2004 5131 5136
19. J.G. Herman p16(INK4) involvement early and often in gastrointestinal malignancies Gastroenterology 116 1999 483 485
20. S.A. Belinsky, K.J. Nikula, W.A. Palmisano Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis Proc Natl Acad Sci USA 95 1998 11891 11896
21. J.G. Herman, J.R. Graff, S. Myohanen Methylation-specific PCR a novel PCR assay for methylation status of CpG islands Proc Natl Acad Sci USA 93 1996 9821 9826
22. Y. Akiyama, N. Watkins, H. Suzuki GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer Mol Cell Biol 23 2003 8429 8439
23. M. van Engeland, M.P. Weijenberg, G.M. Roemen Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer the Netherlands cohort study on diet and cancer Cancer Res 63 2003 3133 3137
24. M. Toyota, L. Shen, M. Ohe-Toyota Aberrant methylation of the cyclooxygenase 2 CpG island in colorectal tumors Cancer Res 60 2000 4044 4048
25. H. Yoshikawa, K. Matsubara, G.S. Qian SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity Nat Genet 28 2001 29 35
26. M. Esteller, P.G. Corn, S.B. Baylin, J.G. Herman A gene hypermethylation profile of human cancer Cancer Res 61 2001 3225 3229
27. B. Yang, M. Guo, J.G. Herman, D.P. Clark Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma Am J Pathol 163 2003 1101 1107
28. M. van Engeland, G.M. Roemen, M. Brink K-ras mutations and RASSF1A promoter methylation in colorectal cancer Oncogene 21 2002 3792 3795
29. C.S. Ng, J. Zhang, S. Wan Tumor p16M is a possible marker of advanced stage in non-small cell lung cancer J Surg Oncol 79 2002 101 106
30. G. Vicidomini, M. Santini, A. Fiorello Intraoperative pleural lavage is it a valid prognostic factor in lung cancer? Ann Thorac Surg 79 2005 254 257
31. M. Esteller, M. Sanchez-Cespedes, R. Rosell Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients Cancer Res 59 1999 67 70
32. K. Kawakami, J. Brabender, R.V. Lord Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma J Natl Cancer Inst 92 2000 1805 1811
33. T.L. Lee, W.K. Leung, M.W. Chan Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma Clin Cancer Res 8 2002 1761 1766
34. M. Sanchez-Cespedes, M. Esteller, L. Wu Gene promoter hypermethylation in tumors and serum of head and neck cancer patients Cancer Res 60 2000 892 895
35. I.H. Wong, Y.M. Lo, J. Zhang Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients Cancer Res 59 1999 71 73
36. S. Jahr, H. Hentze, S. Englisch DNA fragments in the blood plasma of cancer patients quantitations and evidence for their origin from apoptotic and necrotic cells Cancer Res 61 2001 1659 1665
37. B. Shapiro, M. Chakrabarty, E.M. Cohn, S.A. Leon Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease Cancer 51 1983 2116 2120
38. S.A. Leon, B. Shapiro, D.M. Sklaroff, M.J. Yaros Free DNA in the serum of cancer patients and the effect of therapy Cancer Res 37 1977 646 650
39. M. Pellise, A. Castells, A. Gines Detection of lymph node micrometastases by gene promoter hypermethylation in samples obtained by endosonography- guided fine-needle aspiration biopsy Clin Cancer Res 10 2004 4444 4449
40. M. Guo, M.G. House, C. Hooker Promoter hypermethylation of resected bronchial margins a field defect of changes? Clin Cancer Res 10 2004 5131 5136
41. H. Usadel, J. Brabender, K.D. Danenberg Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer Cancer Res 62 2002 371 375